EUVIMEDEUVIMED entdecken
Vergleichsstudie

Folic acid versus folinic acid during methotrexate treatment for low-risk gestational trophoblastic neoplasia

Mehmet Şükrü Budak iD, Süleyman Cemil Oğlak iD, Sedat Akgöl iD, Behzat Can iD, Kevser Arkan iD, Ali Deniz Erkmen iD, Mesut Ali Halisçelik iD, Adnan Budak iD, Şeyhmus Tunç iD, Gökhan Bolluk iD, Emine Zeynep Yılmaz iD, Özgür Akbayır iD

Ginekologia Polska · 2025

DOI: 10.5603/gpl.101142 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Ginekologia Polska, 2025. Verfasst von Mehmet Şükrü Budak und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Private Can Hospital, Izmir, Türkiye. Hauptthemen laut MEDLINE: Methotrexate, Folic Acid, Leucovorin, Gestational Trophoblastic Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateFolic AcidLeucovorinGestational Trophoblastic DiseaseAntimetabolites, AntineoplasticHumansFemalePregnancyAdultRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

folic acidfolinic acidlow-risk gestational trophoblastic neoplasiamethotrexate

Substanzen

MethotrexateFolic AcidLeucovorinAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Private Can Hospital, Izmir, Türkiye.
  • Department of Obstetrics and Gynecology, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Türkiye. sampson_21@hotmail.com.
  • Department of Gynecologic Oncology, Health Sciences University, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Türkiye.
  • Department of Obstetrics and Gynecology, Health Sciences University, Tepecik Training and Research Hospital, Izmir, Türkiye.
  • Department of Obstetrics and Gynecology, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Türkiye.
  • Department of Perinatology, Başakşehir Çam and Sakura City Hospital, Istanbul, Türkiye.

ORCID-Profile: Mehmet Şükrü Budak, Süleyman Cemil Oğlak, Sedat Akgöl, Behzat Can, Kevser Arkan, Ali Deniz Erkmen, Mesut Ali Halisçelik, Adnan Budak, Şeyhmus Tunç, Gökhan Bolluk, Emine Zeynep Yılmaz, Özgür Akbayır

Zitieren

APA

Budak, M. Ş., Oğlak, S. C., Akgöl, S., Can, B., Arkan, K., Erkmen, A. D., Halisçelik, M. A., Budak, A., Tunç, Ş., Bolluk, G., Yılmaz, E. Z., & Akbayır, Ö. (2025). Folic acid versus folinic acid during methotrexate treatment for low-risk gestational trophoblastic neoplasia. Ginekologia Polska. https://doi.org/10.5603/gpl.101142

Vancouver

Budak MŞ, Oğlak SC, Akgöl S, Can B, Arkan K, Erkmen AD, et al. Folic acid versus folinic acid during methotrexate treatment for low-risk gestational trophoblastic neoplasia. Ginekologia Polska. 2025. doi:10.5603/gpl.101142

BibTeX
@article{Budak2025,
  author = {Budak, Mehmet Şükrü and Oğlak, Süleyman Cemil and Akgöl, Sedat and Can, Behzat and Arkan, Kevser and Erkmen, Ali Deniz and Halisçelik, Mesut Ali and Budak, Adnan and Tunç, Şeyhmus and Bolluk, Gökhan and Yılmaz, Emine Zeynep and Akbayır, Özgür},
  title = {Folic acid versus folinic acid during methotrexate treatment for low-risk gestational trophoblastic neoplasia},
  journal = {Ginekologia Polska},
  year = {2025},
  doi = {10.5603/gpl.101142}
}
Kostenlos starten →